Intraocular Lenses

Valeant, Croma agreement to expand B + L surgical lineThe recent agreement between Valeant and Croma—which would provide for the distribution of Croma’s ophthalmology products in Western Europe—is expected to expand Bausch + Lomb’s (B + L) ophthalmic portfolio in the United States.
Editor’s Blog: IOLs again grab the attention at ESCRSThe European Society of Cataract and Refractive Surgeons (ESCRS) never fails to entice ophthalmology with cutting-edge technology, and the XXXII Congress in London has not disappointed attendees. This year’s congress has displayed a wide range of new technologies from cataract and refractive platforms to diagnostic units to surgical instruments. From all the equipment presented, IOL advances have again captured the attention of attendees.
FDA extends UDI compliance date for most contact lensesThe deadline for the U.S. Food and Drug Administration’s (FDA) Unique Device Identification (UDI) rule has been extended for an additional year for some medical device manufacturers.
Alcon to acquire WaveTec VisionAlcon has entered into an agreement to acquire WaveTec Vision, developer of the ORA System, the first commercialized intraoperative guidance system for cataract surgeons implanting intraocular lenses (IOLs).
How to manage aphakic correction in eyes without capsular supportThe decision on IOL type and fixation method in eyes without adequate capsular support should take into account the specific clinical presentation.
The pros and cons of clear lens exchangeMore and more well-informed individuals are requesting lens extraction for refractive purposes even though their natural lenses are clear.
Trifocal IOL facilitates intermediate visionA diffractive trifocal IOL (FineVision, PhysIOL) provides a peak modulation transfer function for intermediate vision.
Dual-optic lens accommodates vision at all distancesA dual-optic accommodating IOL (Synchrony, Abbott Medical Optics) seems to have met the presbyopic challenge by providing good vision at far and intermediate distances.
Innovative IOL technology fills pipelineAn array of IOLs under development and in clinical trials show promise for correcting presbyopia or addressing other limitations of existing pseudophakic lenses.
Carl Zeiss buys IOL manufacturer Aaren ScientificCarl Zeiss Meditec AG announced it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a U.S.-based manufacturer of intraocular lenses (IOLs).